Hepione Therapeutics Inc
Biotechnology company · New York, United States
Hepione Therapeutics Inc is a biotechnology company headquartered in New York, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $261,742 in total, most recently in 2020.
Profile compiled from public records. Is this your company? Request a correction or update
Hepione Therapeutics at a glance
Typebiotechnology company
HeadquartersNew York, United States
Employees (self-reported, 2020)4
What does Hepione Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $261,742 in total (2020). NIH funding came from the National Institute on Drug Abuse.
Frequently asked questions about Hepione Therapeutics
Where is Hepione Therapeutics headquartered?
Hepione Therapeutics Inc is headquartered in New York, United States.
What does Hepione Therapeutics do?
Hepione Therapeutics Inc is a biotechnology company.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences